Atai stock forecast.

13.80 0.00 0.00% The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock …WebATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary. Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Somalogic Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.30. The median estimate ...

When is Atai Life Sciences's earnings date? Atai Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 22nd, 2024 based off last year's report dates. Learn more on ATAI's earnings history.Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!

RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Jul 28, 2022 · Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ... When is Atai Life Sciences's earnings date? Atai Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 22nd, 2024 based off last year's report dates. Learn more on ATAI's earnings history.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Find the latest Applied Digital Corporation (APLD) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...The stock ranks in the lowest position of the 53 stocks owned by the ETF. Atai was the third psychedelics company to go public with an IPO in June 2021, following Mind Medicine Inc MNMD and ...

Jun 2, 2022 · Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. See why ATAI stock is a buy.

ATAI Life Sciences N.V. (ATAI) stock forecast and price target. Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends …Web

The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.055893, which would represent a -2.23% loss compared to the current price. In the next week, the price of ATAI is expected to decrease by -18.90% and hit $ 0.875911. As far as the long-term Atai Life Sciences N.V. stock forecast is ...18. 6. 2021. ... Atai Life Sciences, a biotech company that uses psychedelics to treat ... Stock ScreenerNEW! Market Forecast · Options Investing; Subscribe; Sign ...13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information.Find the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Dividend History. Dividend Yield Chart. Learn more about Atai Life Sciences's (ATAI) dividend history, ex-dividend date, and yield. Zacks.com Our Research, Your Success.ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low.

13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...28.98. According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. …WebJun 15, 2021 · Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock. Atai Life Sciences ( ATAI) seems focused on structuring. Investors will want to see meaningful financial results that go beyond job cuts. The psychedelic drug boom may be taking off, but one ...

Exela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …Atai Capital believes showing returns net of a 1.50% management fee better reflects actual performance as of 07/12/2023 since no account that Atai Capital currently manages is charged a fee more ...

Find the latest Navitas Semiconductor Corporation (NVTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short ...The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.Description. بايثون هي واحده من اكثر لغات البرمجه انتشارا في العالم واسهلهم واقواهم. اللعه مستخدمه تقريبا في اغلب التطبيقات اللي بنستخدمها في حياتنا اليوميه زي Youtube , Google Search , Instagram , Quora , Pinterest ...Atai Life Sciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,630,000 shares, an increase of 20.6% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...1.04%. $183.15M. AMAM | Complete Ambrx Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. Apr 13, 2023 · Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to ... NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more. According to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,015.70%. The lowest …WebGet actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Aptinyx Inc APTX Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.

ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ...

See ATAI Life Sciences N.V. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.

According to 6 analyst offering 12-month price targets in the last 3 months, ATAI Life Sciences has an average price target of $15.33 with a high of $23.00 and a low of $9.00. Below is a summary ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.The stock has given up three-quarters of its market value year to date. Ark Genomic bought 67,384 shares of Atai Life Sciences - Get Free Report, valued at $284,360. Atai is a Berlin ...As of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ... Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.May 25, 2023 · These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ... ATAI / ATAI Life Sciences N.V. - Forecast and Price Target https://fintel.io/sfo/us/atai. See More. Bullish. Reply. Keep. Last Read. Share. Copy Message ...Atai Life Sciences (ATAI) Stock Forecast & Price Target $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52 …WebFind real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.NEW YORK and BERLIN, Aug. 10, 2023-- atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported second quarter 2023 ...

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...Find real-time DTIL - Precision BioSciences Inc stock quotes, company profile, news and forecasts from CNN Business.The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.Instagram:https://instagram. ceo of shopifybest books for beginning investorssna.best firearm theft insurance Apr 6, 2023 · The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ... Apr 13, 2023 · Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to ... mortgage lenders during chapter 13can you make money on currency trading atai Life Sciences N.V. Wallstraße 16 10179 Berlin, Germany Statutory Seat Amsterdam research stocks See the latest Vista Energy SAB de CV ADR stock price (VIST:XNYS), related ... ATAI Life Sciences, LianBio, or BioXcel Therapeutics? PR Newswire Oct 26, 2023 ...Atai Capital believes showing returns net of a 1.50% management fee better reflects actual performance as of 07/12/2023 since no account that Atai Capital currently manages is charged a fee more ...13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...